Eli Lilly Pill Shows Significant Weight Loss in Trial

Eli Lilly's new pill, orforglipron, has shown promising results in causing significant weight loss in adults with obesity, with an average loss of 27.3 pounds at the highest dose, and the company plans to seek FDA approval by the end of the year. The pill offers a potentially more accessible alternative to injectable weight-loss drugs, with manufacturing advantages, though its full efficacy and safety profile are yet to be fully disclosed.